323 related articles for article (PubMed ID: 19211603)
1. Effect of topical atropine on astigmatism.
Chia A; Chua WH; Tan D
Br J Ophthalmol; 2009 Jun; 93(6):799-802. PubMed ID: 19211603
[TBL] [Abstract][Full Text] [Related]
2. Atropine for the treatment of childhood myopia.
Chua WH; Balakrishnan V; Chan YH; Tong L; Ling Y; Quah BL; Tan D
Ophthalmology; 2006 Dec; 113(12):2285-91. PubMed ID: 16996612
[TBL] [Abstract][Full Text] [Related]
3. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
[TBL] [Abstract][Full Text] [Related]
4. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
[TBL] [Abstract][Full Text] [Related]
5. Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial.
Wang M; Cui C; Sui Y; Yu SA; Ma JX; Fu AC
BMC Ophthalmol; 2022 Apr; 22(1):161. PubMed ID: 35392841
[TBL] [Abstract][Full Text] [Related]
6. Incidence and progression of astigmatism in Singaporean children.
Tong L; Saw SM; Lin Y; Chia KS; Koh D; Tan D
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):3914-8. PubMed ID: 15505036
[TBL] [Abstract][Full Text] [Related]
7. One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia.
Tan DT; Lam DS; Chua WH; Shu-Ping DF; Crockett RS;
Ophthalmology; 2005 Jan; 112(1):84-91. PubMed ID: 15629825
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Changes in Refraction and Biometry of Atropine- and Placebo-Treated Eyes.
Kumaran A; Htoon HM; Tan D; Chia A
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5650-5. PubMed ID: 26313301
[TBL] [Abstract][Full Text] [Related]
9. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
[TBL] [Abstract][Full Text] [Related]
10. Tropicamide and myopia progression.
Iribarren R
Ophthalmology; 2008 Jun; 115(6):1103-4; author reply 1104. PubMed ID: 18519078
[No Abstract] [Full Text] [Related]
11. Management of progressive school myopia with topical atropine eyedrops and photochromic bifocal spectacles.
Romano PE; Donovan JP
Binocul Vis Strabismus Q; 2000; 15(3):257-60. PubMed ID: 10960233
[TBL] [Abstract][Full Text] [Related]
12. Role of parental myopia in the progression of myopia and its interaction with treatment in COMET children.
Kurtz D; Hyman L; Gwiazda JE; Manny R; Dong LM; Wang Y; Scheiman M;
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):562-70. PubMed ID: 17251451
[TBL] [Abstract][Full Text] [Related]
13. Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students.
Kennedy RH; Dyer JA; Kennedy MA; Parulkar S; Kurland LT; Herman DC; McIntire D; Jacobs D; Luepker RV
Binocul Vis Strabismus Q; 2000; 15(3 Suppl):281-304. PubMed ID: 11486796
[TBL] [Abstract][Full Text] [Related]
14. Corneal power and astigmatism in Down syndrome.
Little JA; Woodhouse JM; Saunders KJ
Optom Vis Sci; 2009 Jun; 86(6):748-54. PubMed ID: 19390470
[TBL] [Abstract][Full Text] [Related]
15. Effect of pirenzepine ophthalmic solution on form-deprivation myopia in the guinea pigs.
Le QH; Cheng NN; Wu W; Chu RY
Chin Med J (Engl); 2005 Apr; 118(7):561-6. PubMed ID: 15861568
[TBL] [Abstract][Full Text] [Related]
16. A combined therapy using stimulating auricular acupoints enhances lower-level atropine eyedrops when used for myopia control in school-aged children evaluated by a pilot randomized controlled clinical trial.
Liang CK; Ho TY; Li TC; Hsu WM; Li TM; Lee YC; Ho WJ; Cheng JT; Tzeng CY; Liu IT; Chang SL
Complement Ther Med; 2008 Dec; 16(6):305-10. PubMed ID: 19028329
[TBL] [Abstract][Full Text] [Related]
17. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study.
Li FF; Kam KW; Zhang Y; Tang SM; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC
Ophthalmology; 2020 Dec; 127(12):1603-1611. PubMed ID: 32525048
[TBL] [Abstract][Full Text] [Related]
18. Does atropine use increase intraocular pressure in myopic children?
Wu TE; Yang CC; Chen HS
Optom Vis Sci; 2012 Feb; 89(2):E161-7. PubMed ID: 22105331
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of astigmatism as a function of age in a Hong Kong clinical population.
Leung TW; Lam AK; Deng L; Kee CS
Optom Vis Sci; 2012 Jul; 89(7):984-92. PubMed ID: 22705776
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for progressive myopia in the atropine therapy for myopia study.
Loh KL; Lu Q; Tan D; Chia A
Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
